Skip to main content
Chiome Bioscience Inc. logo

Chiome Bioscience Inc. — Investor Relations & Filings

Ticker · 4583 ISIN · JP3205350006 T Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2023-03-28 Regulatory Filings
Country JP Japan
Listing T 4583

About Chiome Bioscience Inc.

https://www.chiome.co.jp/

Chiome Bioscience Inc. is a clinical-stage biotechnology company specializing in the research and development of antibody-based therapeutics. The company leverages its proprietary ADLib® system, an innovative antibody generation technology, to discover and develop fully human monoclonal antibodies. Its primary mission is to address unmet medical needs by creating novel antibody drugs. The company's operations focus on the early stages of the drug discovery and development process, including initial research and early-phase clinical trials.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act Article 24-4-2. It serves as an officer certification regarding the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2022
2023-03-28 Japanese
内部統制報告書－第19期(2022/01/01－2022/12/31)
Governance Information Classification · 1% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). This type of report is a mandatory regulatory filing in Japan that assesses the effectiveness of a company's internal controls over financial reporting. Since it is a specific regulatory requirement that does not fit into the categories of Annual Reports (10-K), Earnings Releases (ER), or other specific financial statements, it falls under the 'Regulatory Filings' category.
2023-03-28 Japanese
有価証券報告書－第19期(2022/01/01－2022/12/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial data, management analysis, business history, and corporate information for the fiscal year ending December 31, 2022. It is a full annual report, not an announcement or a summary. FY 2022
2023-03-28 Japanese
確認書
Regulatory Filings
2022-11-14 Japanese
四半期報告書－第19期第3四半期(令和4年7月1日－令和4年9月30日)
Interim / Quarterly Report
2022-11-14 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-8 of the Financial Instruments and Exchange Act of Japan, which accompanies a Quarterly Report (Dai-ni shihanki hokokusho). Since this document is a formal regulatory filing confirming the accuracy of the quarterly report and is not the quarterly report itself, it falls under the category of general regulatory filings.
2022-08-10 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.